Skip to main content
main-content

24-10-2018 | Head and neck cancer | Video

De-ESCALaTE HPV results revealed

Hisham Mehanna describes the results of the De-ESCALaTE HPV  trial comparing cetuximab versus cisplatin for the treatment of low-risk oropharyngeal cancer patients undergoing radiotherapy (5:43).

Funding for this video was provided in part by F. Hoffmann-La Roche Ltd, Basel, Switzerland.

Image Credits